Efficacy and Safety of Omalizumab in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial

Journal article

Thomas B. Casale, Marcus Maurer, Hsin-Ju Hsieh, Janice Canvin, Sarbjit S. Saini, Clive Grattan, Ana Gimenez-Arnau, Allen P. Kaplan and Karin Rosen

Journal of Allergy and Clinical Immunology, Vol.131(2, Supplement), p.AB327

2013

Metrics

5 Record Views

Title: Efficacy and Safety of Omalizumab in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
Creators: Thomas B. Casale (Author) - Creighton University
Marcus Maurer (Author)
Hsin-Ju Hsieh (Author)
Janice Canvin (Author)
Sarbjit S. Saini (Author)
Clive Grattan (Author)
Ana Gimenez-Arnau (Author)
Allen P. Kaplan (Author)
Karin Rosen (Author)
Publication Details: Journal of Allergy and Clinical Immunology, Vol.131(2, Supplement), p.AB327
Number of pages: AB327
Identifiers: 991005930778602656
Academic Unit: School of Medicine; Allergy-Immunology
Resource Type: Journal article